Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Lee

Showing results (531-540 of 594) with videos related to

Pageof 60
Sort By:
The Oncologist|May 8, 2023
Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center ExperienceMehmet Altan, Felipe Soto, Linda L Zhong, et al.
Cancers|January 8, 2023
Habitat Imaging Biomarkers for Diagnosis and Prognosis in Cancer Patients Infected with COVID-19Muhammad Aminu, Divya Yadav, Lingzhi Hong, et al.
Nature Medicine|January 16, 2026
Nous-209 neoantigen vaccine for cancer prevention in Lynch syndrome carriers: a phase 1b/2 trialAnna Morena D'Alise, Jason Willis, Fahriye Duzagac, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2013
Comprehensive biomarker analysis and final efficacy results of sorafenib in the BATTLE trialGeorge R Blumenschein, Pierre Saintigny, Suyu Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2025
First-line MET tyrosine kinase inhibitors versus immunotherapy ± chemotherapy for patients with MET exon 14 skipping mutant metastatic NSCLCFederica Pecci, Hui Li, Alessandro Di Federico, et al.
Ebiomedicine|June 21, 2016
Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate CancerJeri Kim, John W Davis, Eric A Klein, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 7, 2023
Pathomic Features Reveal Immune and Molecular Evolution From Lung Preneoplasia to Invasive AdenocarcinomaPingjun Chen, Frank R Rojas, Xin Hu, et al.
Oncotarget|July 1, 2015
Long-term results of a randomized phase III trial of TPF induction chemotherapy followed by surgery and radiation in locally advanced oral squamous cell carcinomaLai-ping Zhong, Chen-ping Zhang, Guo-xin Ren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2014
Mutational landscape of aggressive cutaneous squamous cell carcinomaCurtis R Pickering, Jane H Zhou, J Jack Lee, et al.
Lancet (London, England)|July 21, 2023
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trialJoe Y Chang, Steven H Lin, Wenli Dong, et al.
Pageof 60

Showing results (531-540 of 594) with videos related to

Sort By:
Pageof 60
The Oncologist|May 8, 2023
Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center ExperienceMehmet Altan, Felipe Soto, Linda L Zhong, et al.
Cancers|January 8, 2023
Habitat Imaging Biomarkers for Diagnosis and Prognosis in Cancer Patients Infected with COVID-19Muhammad Aminu, Divya Yadav, Lingzhi Hong, et al.
Nature Medicine|January 16, 2026
Nous-209 neoantigen vaccine for cancer prevention in Lynch syndrome carriers: a phase 1b/2 trialAnna Morena D'Alise, Jason Willis, Fahriye Duzagac, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2013
Comprehensive biomarker analysis and final efficacy results of sorafenib in the BATTLE trialGeorge R Blumenschein, Pierre Saintigny, Suyu Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2025
First-line MET tyrosine kinase inhibitors versus immunotherapy ± chemotherapy for patients with MET exon 14 skipping mutant metastatic NSCLCFederica Pecci, Hui Li, Alessandro Di Federico, et al.
Ebiomedicine|June 21, 2016
Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate CancerJeri Kim, John W Davis, Eric A Klein, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 7, 2023
Pathomic Features Reveal Immune and Molecular Evolution From Lung Preneoplasia to Invasive AdenocarcinomaPingjun Chen, Frank R Rojas, Xin Hu, et al.
Oncotarget|July 1, 2015
Long-term results of a randomized phase III trial of TPF induction chemotherapy followed by surgery and radiation in locally advanced oral squamous cell carcinomaLai-ping Zhong, Chen-ping Zhang, Guo-xin Ren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2014
Mutational landscape of aggressive cutaneous squamous cell carcinomaCurtis R Pickering, Jane H Zhou, J Jack Lee, et al.
Lancet (London, England)|July 21, 2023
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trialJoe Y Chang, Steven H Lin, Wenli Dong, et al.
Pageof 60